AbbVie Inc. — Director's Dealing 2013

Dec 20, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2013-12-19

Reporting Person: CHASE WILLIAM J (EVP, Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-12-19	Common stock, $0.01 par value	M	963	$28.9667	Acquired	139619	Direct
2013-12-19	Common stock, $0.01 par value	M	1620	$34.4889	Acquired	141239	Direct
2013-12-19	Common stock, $0.01 par value	M	1591	$35.2421	Acquired	142830	Direct
2013-12-19	Common stock, $0.01 par value	M	3438	$35.985	Acquired	146268	Direct
2013-12-19	Common stock, $0.01 par value	F	6149	$54.32	Disposed	140119	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-12-19	Option (right to buy)	$28.9667	M	963	Disposed	2014-02-19	Common stock (963)	Direct
2013-12-19	Option (right to buy)	$34.4889	M	1620	Disposed	2014-02-19	Common stock (1620)	Direct
2013-12-19	Option (right to buy)	$35.2421	M	1591	Disposed	2014-02-19	Common stock (1591)	Direct
2013-12-19	Option (right to buy)	$35.985	M	3438	Disposed	2014-02-19	Common stock (3438)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock, $0.01 par value	501	Indirect

Footnotes

F1: Held by spouse in the AbbVie Savings Program as of December 19, 2013. The reporting person disclaims beneficial ownership of all securities held by his spouse.